CVS HEALTH CORP
CVSNYSETrading Snapshot
- Day Range
- $89.89 – $91.53
- 52-Week Range
- $69.51 – $110.68
- Volume (shares)
- 5,575,605
- Avg Volume (shares)
- —
- Shares Outstanding
- 1.28B
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $402.07B
- Last Q Revenue
- $106.10B
- P/E Ratio
- 24.6
- P/S Ratio
- 0.3x
- EPS (TTM)
- $3.77
- Dividend Yield
- 2.84%
- Dilution (1yr)
- +1.3%
CVS HEALTH CORP
CVS
StockOtter · stockotter.spaceAbout CVS HEALTH CORP
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
CVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term
CVS Health has executed a robust turnaround, prompting an upgrade from hold to buy with a $115 price target. Accelerating earnings, raised guidance, improved margins, and reduced leverage underpin a strengthened long-ter
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) ana
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
CVS Health (CVS) closed the most recent trading day at $91.13, moving 1.51% from the previous trading session.
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p
CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigati
Should You Buy CVS Health Stock While It's Under $100?
After a couple of challenging years, CVS Health has been generating some improved numbers in 2026. The company is expecting a significant improvement on the bottom line this year.